Respiratory disease in practice - 2010


Combination inhalers for asthmas: a review of the available options
Julian Brown
pp 1-5
Combination preparations of an inhaled steroid and a long-acting beta2-agonist (LABA) have been used for the management of asthma and chronic obstructive pulmonary disease (COPD) since Seretide (A&H, UK) was first launched in March 1999. Seretide is the most expensive drug for the NHS, costing over £344 million per year.
Comment: Bronchiectasis – the 'Cinderella' of airway diseases
Philip W Ind
pp 3-3
This issue of Respiratory disease in practice includes articles on inhaled steroid/long-acting beta2 agonist combination inhalers in asthma, video-assisted thoracoscopic surgery, a novel community-based approach to care for chronic obstructive pulmonary disease (COPD), and pre-operative assessment of respiratory patients.
Using video-assisted thoracoscopic surgery
Amir Sadri and Eric Lim
pp 6-7
Video-assisted thoracoscopic surgery (VATS) is the term for conducting a thoracic procedure with the assistance of a video camera, in which the size of surgical access into the chest cavity is reduced to one or more small incisions.
The BreathingSpace project for community care in COPD
Gail South
pp 8-9
Chronic obstructive pulmonary disease (COPD) is a cause of significant morbidity and mortality throughout the UK, but there are some areas with a particularly high prevalence of disease. One such place is Rotherham. A former mining community, it was chosen as a site of an innovative and ambitious project to change the way in which care for patients with COPD is delivered.
Preparing respiratory patients for surgery
Mary McGinty
pp 10-11
Respiratory disease causing chronic respiratory impairment affects 20% of the population in the UK. Many of these patients have chronic obstructive pulmonary disease (COPD), but there are other respiratory diseases of interest to the surgical team. Respiratory disease (especially COPD) is also a marker for other undiagnosed co-morbidity such as ischaemic heart disease.